1. Home
  2. CLYM vs THTX Comparison

CLYM vs THTX Comparison

Compare CLYM & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLYM
  • THTX
  • Stock Information
  • Founded
  • CLYM 2018
  • THTX 1993
  • Country
  • CLYM United States
  • THTX Canada
  • Employees
  • CLYM N/A
  • THTX N/A
  • Industry
  • CLYM
  • THTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLYM
  • THTX Health Care
  • Exchange
  • CLYM NYSE
  • THTX Nasdaq
  • Market Cap
  • CLYM 101.6M
  • THTX 93.3M
  • IPO Year
  • CLYM 2021
  • THTX N/A
  • Fundamental
  • Price
  • CLYM $1.47
  • THTX $1.85
  • Analyst Decision
  • CLYM
  • THTX Hold
  • Analyst Count
  • CLYM 0
  • THTX 1
  • Target Price
  • CLYM N/A
  • THTX N/A
  • AVG Volume (30 Days)
  • CLYM 331.6K
  • THTX 90.9K
  • Earning Date
  • CLYM 03-27-2025
  • THTX 04-09-2025
  • Dividend Yield
  • CLYM N/A
  • THTX N/A
  • EPS Growth
  • CLYM N/A
  • THTX N/A
  • EPS
  • CLYM N/A
  • THTX N/A
  • Revenue
  • CLYM N/A
  • THTX $84,316,000.00
  • Revenue This Year
  • CLYM N/A
  • THTX $5.78
  • Revenue Next Year
  • CLYM N/A
  • THTX $2.47
  • P/E Ratio
  • CLYM N/A
  • THTX N/A
  • Revenue Growth
  • CLYM N/A
  • THTX 5.75
  • 52 Week Low
  • CLYM $1.41
  • THTX $1.08
  • 52 Week High
  • CLYM $11.55
  • THTX $2.18
  • Technical
  • Relative Strength Index (RSI)
  • CLYM N/A
  • THTX 58.80
  • Support Level
  • CLYM N/A
  • THTX $1.56
  • Resistance Level
  • CLYM N/A
  • THTX $2.06
  • Average True Range (ATR)
  • CLYM 0.00
  • THTX 0.14
  • MACD
  • CLYM 0.00
  • THTX 0.04
  • Stochastic Oscillator
  • CLYM 0.00
  • THTX 68.84

About CLYM CLIMB BIO INC

Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its lead product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Share on Social Networks: